Wanbury Limited (NSE:WANBURY)
268.45
-0.45 (-0.17%)
Aug 1, 2025, 3:29 PM IST
Wanbury Employees
Wanbury had 1,491 employees as of March 31, 2024. The number of employees decreased by 91 or -5.75% compared to the previous year.
Employees
1,491
Change (1Y)
-91
Growth (1Y)
-5.75%
Revenue / Employee
4.02M INR
Profits / Employee
204.76K INR
Market Cap
8.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1,491 | -91 | -5.75% |
Mar 31, 2023 | 1,582 | 198 | 14.31% |
Mar 31, 2022 | 1,384 | 228 | 19.72% |
Mar 31, 2021 | 1,156 | -281 | -19.55% |
Mar 31, 2020 | 1,437 | -319 | -18.17% |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Mankind Pharma | 26,978 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Aurobindo Pharma | 26,015 |
Wanbury News
- 5 weeks ago - Wanbury launches next-gen iron supplement ‘C RED’ to revolutionize anemia management in India - Business Upturn
- 2 months ago - Wanbury receives GMP certification from ANVISA for Patalganga facility - Business Upturn
- 2 months ago - Wanbury’s Tanuku facility in Andhra Pradesh completes ANVISA inspection with zero observations - Business Upturn
- 4 months ago - Wanbury launches Wanbury C-RED and Ketamine Hydrochloride - Business Upturn
- 5 months ago - Wanbury shares rise 2.56% following company refinances Rs 95 crore NCDs, reducing interest costs - Business Upturn
- 5 months ago - Wanbury secures lower-cost refinancing for outstanding debentures - Business Upturn
- 7 months ago - Wanbury completes successful ANVISA audit at Tanuku facility - Business Upturn